Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China
· Delayed Price · Currency is CNY 4.520
+0.030 (0.67%)
Jun 20, 2025, 2:45 PM CST
Shanghai Kinetic Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -94.69 | -105.57 | 112.54 | -21.28 | 161.78 | -126.54 | Upgrade
|
| Depreciation & Amortization | 68.43 | 68.43 | 65.83 | 60.9 | 56.81 | 33.06 | Upgrade
|
| Other Amortization | 14.01 | 14.01 | 12.16 | 13.38 | 11.81 | 2.37 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.1 | 0.1 | 0.37 | 0.21 | -1.6 | -0.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.91 | 2.91 | 0.58 | 200 | 149.4 | 365.63 | Upgrade
|
| Loss (Gain) From Sale of Investments | 193.26 | 193.26 | -30.63 | 28.9 | -47.79 | -4.61 | Upgrade
|
| Provision & Write-off of Bad Debts | 2.38 | 2.38 | -8.96 | 19.66 | 11.5 | 11 | Upgrade
|
| Other Operating Activities | 49.8 | 32.67 | 23.38 | 11.85 | 38.82 | 28.48 | Upgrade
|
| Change in Accounts Receivable | -60.96 | -60.96 | -214.81 | 149.93 | 45.61 | 145.52 | Upgrade
|
| Change in Inventory | -29.1 | -29.1 | -21.89 | -49.65 | -60.62 | -15.8 | Upgrade
|
| Change in Accounts Payable | 67.22 | 67.22 | 336.82 | -174.18 | 38.11 | -175.63 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | -26.98 | 25.67 | Upgrade
|
| Operating Cash Flow | 185.76 | 157.75 | 274.26 | 236.76 | 378.16 | 284.92 | Upgrade
|
| Operating Cash Flow Growth | 4.21% | -42.48% | 15.84% | -37.39% | 32.72% | 11.47% | Upgrade
|
| Capital Expenditures | -94.51 | -82.84 | -53.79 | -41.45 | -49.21 | -29.6 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.22 | 0.29 | 0.49 | 0.84 | 4.87 | 3.65 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -64.73 | -163.91 | Upgrade
|
| Divestitures | 0.3 | - | 9.37 | 1.4 | 30.5 | 35.16 | Upgrade
|
| Investment in Securities | -461.2 | -459.42 | -168.58 | -132.14 | -37.69 | -176.33 | Upgrade
|
| Other Investing Activities | 201.45 | 19.64 | 11.85 | 8.59 | 7.04 | 8.29 | Upgrade
|
| Investing Cash Flow | -353.75 | -522.33 | -186.67 | -163.78 | -109.22 | -322.74 | Upgrade
|
| Long-Term Debt Issued | - | 310.26 | 175.7 | 172.82 | 293.08 | 354.48 | Upgrade
|
| Long-Term Debt Repaid | - | -196.97 | -346.01 | -215.42 | -456.71 | -376.84 | Upgrade
|
| Net Debt Issued (Repaid) | 73.45 | 113.29 | -170.31 | -42.6 | -163.62 | -22.36 | Upgrade
|
| Common Dividends Paid | -46.49 | -46.14 | -5.11 | -47.23 | -54.86 | -56.09 | Upgrade
|
| Other Financing Activities | 11.34 | 2.71 | -1.49 | -14.26 | -20.47 | -5.03 | Upgrade
|
| Financing Cash Flow | 38.29 | 69.86 | -176.91 | -104.09 | -238.95 | -83.47 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.59 | 0.85 | 1.67 | 11.97 | -3.03 | -10.05 | Upgrade
|
| Net Cash Flow | -129.11 | -293.87 | -87.64 | -19.14 | 26.96 | -131.34 | Upgrade
|
| Free Cash Flow | 91.25 | 74.91 | 220.47 | 195.3 | 328.94 | 255.32 | Upgrade
|
| Free Cash Flow Growth | -23.51% | -66.02% | 12.89% | -40.63% | 28.84% | 18.61% | Upgrade
|
| Free Cash Flow Margin | 9.10% | 7.61% | 23.06% | 16.75% | 25.93% | 24.05% | Upgrade
|
| Free Cash Flow Per Share | 0.13 | 0.10 | 0.31 | 0.27 | 0.46 | 0.35 | Upgrade
|
| Cash Interest Paid | 0.54 | 0.54 | 0.18 | 0.85 | 2.31 | 2.13 | Upgrade
|
| Cash Income Tax Paid | 42.47 | 36.17 | 63.87 | 131.29 | 123.06 | 143.38 | Upgrade
|
| Levered Free Cash Flow | 79.11 | 55.1 | 190.28 | 160.13 | -135.88 | 415.6 | Upgrade
|
| Unlevered Free Cash Flow | 83.63 | 59.27 | 194.38 | 168.96 | -121.71 | 429.59 | Upgrade
|
| Change in Net Working Capital | -40.25 | -10.21 | -120.32 | -3.47 | 289.37 | -238.79 | Upgrade
|
Updated Oct 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.